Vanda Pharmaceuticals Inc. (LON:0LKB)
London · Delayed Price · Currency is GBP · Price in USD 5.05
+0.08 (1.60%)
At close: Dec 3, 2025
Vanda Pharmaceuticals Market Cap
Vanda Pharmaceuticals has a market cap or net worth of 239.08 million as of December 5, 2025. Its market cap has increased by 5.62% in one year.
Market Cap
239.08M
Enterprise Value
26.79M
Revenue
157.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.05
Market Cap Chart
Since April 12, 2006, Vanda Pharmaceuticals's market cap has increased from 119.67M to 239.08M, an increase of 99.79%. That is a compound annual growth rate of 3.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 239.08M | 7.16% |
| Dec 31, 2024 | 223.09M | 17.04% |
| Dec 29, 2023 | 190.61M | -45.08% |
| Dec 30, 2022 | 347.09M | -46.23% |
| Dec 31, 2021 | 645.56M | 22.64% |
| Dec 31, 2020 | 526.37M | -20.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.77B |
| HSBC Holdings | 182.10B |
| Shell | 158.59B |
| Unilever | 110.94B |
| Rio Tinto Group | 94.53B |
| British American Tobacco p.l.c. | 93.13B |
| Rolls-Royce Holdings | 90.78B |
| GSK plc | 72.45B |